Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Longevity Market to reach USD 67.03B by 2035, driven by preventive care, AI innovations, and rising demand for personalized and regenerative therapies.
-
VANCOUVER, BRITISH COLUMBIA, April 10, 2026 (GLOBE NEWSWIRE) -- 1470370 B.C. Ltd. (the “Company”) announces that the Board of Directors of the Company has approved a subdivision of its common shares...
-
NEW YORK and SEOUL, South Korea, April 10, 2026 (GLOBE NEWSWIRE) -- K Wave Media Ltd. (“KWM” or the “Company”) (NASDAQ: KWM), a global K-content, intellectual property (IP), and artificial...
-
NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- NetworkNewsWire Editorial Coverage: Escalating geopolitical tensions and renewed disruptions to key shipping corridors, particularly around the Strait of...
-
BOCA RATON, Fla., April 10, 2026 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (NASDAQ: NEWT) (“NewtekOne” or the “Company”) announced that its subsidiary Newtek ALP Holdings has paid down to $0 two credit...
-
NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- via AINewsWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by AINewsWire ("AINW"), one of 75+...
-
Judgment of the Solna District Court in a dispute concerning Luotea Oyj's group company Luotea FM AB
Luotea PlcStock Exchange Release10. April 2026 at 3.30 pm EET Judgment of the Solna District Court in a dispute concerning Luotea Oyj's group company Luotea FM AB Summary of the judgment The...
-
WEST PALM BEACH, FL, April 10, 2026 (GLOBE NEWSWIRE) -- AVAX One Technology Ltd. (Nasdaq: AVX) (“AVAX One” or the "Company"), today announced its participation in the upcoming Centri Capital...
-
MCLEAN, Va., April 10, 2026 (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: CYCU) (“Cycurion” or the “Company”), a leading provider of advanced IT cybersecurity solutions and AI-driven innovations for...
-
Financing secures path to first NDA submission for buntanetap6-Month symptomatic data readout anticipated Q1 2027Alzheimer’s disease Phase 3 trial 75% enrolledParkinson's disease open-label study 28%...